Search
Skip to content
  • Login
  • Home
  • About Us
    • About Us
    • Board of Directors
    • NASADAD Staff
  • Contact Us
  • Mobile Menus
Public View

Buprenorphine Patient Limits: History and Overview

Image January 30, 2019 SWickramatilake

Download (PDF, 341KB)

Post navigation

Previous PostComments to CMS on Medicare Payment for Certain Services Furnished by Opioid Treatment ProgramsNext PostNASADAD releases overview of buprenorphine patient limits
  • Our Members
    • Role of State Alcohol and Drug Agencies
  • NASADAD Annual Meeting
  • Public Policy
    • Legislative Summaries
    • Federal Budget and Appropriations
    • Partnerships for Success Information
    • NASADAD Fact Sheets
    • NASADAD Policy Statements
    • Public Policy Issue Briefs
    • NASADAD Presentations
    • D.C. Updates
    • Hot Topics
    • Letters & Regulatory Comments
    • State Specific Information
    • Health Reform Information
    • Members Only
  • Prevention
    • National Prevention Network
    • NPN Conference
    • Innovative Substance Abuse Prevention Programs, Practices and Policies
    • National Prevention Resources
  • Treatment & Recovery
    • National Treatment Network
    • Women’s Services Network
    • Opioid Treatment Network
    • HIV Coordinators
    • Youth Coordinators
    • State Treatment & Recovery Resources
  • Resources
    • NASADAD Reports
    • Federal Resources
    • NASADAD Component Groups
    • Research
  • Job Postings
  • COVID-19 Resources
    • Providers
    • Facilities
    • Telehealth
    • Benefits & Funding
    • Communities
    • Recovery Support Services
  • Show Member Menus
© National Association of State Alcohol and Drug Abuse Directors